Form D · Pharmaceuticals
CHARLESTON LABORATORIES INC
Charleston, SC · CIK 0001453665
Offering snapshot reported Oct 1, 2012 · SEC filing
- Reported sold
- $7.42M Offering amount: $13M
- Investors reported
- 49 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 13, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2012 | Initial | $7,415,026 | No comparison | 49 | SEC filing |
| Jan 5, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184862
Source: Form D, filed Oct 1, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Bosse | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
65 Gadsden Street Suite 201
Charleston, SC, 29401
Charleston, SC, 29401